Bruker (BRKR) Tops Q4 EPS by 1c, Offers Guidance

Bruker (NASDAQ: BRKR) reported Q4 EPS of $0.59, $0.01 better than the analyst estimate of $0.58. Revenue for the quarter came in at $683.5 million versus the consensus estimate of $663.88 million.

GUIDANCE:

Bruker sees Q1 2022 EPS of $2.29-$2.33, versus the consensus of $2.29.

• For FY 2022, Bruker expects approximately 5% to 7% year-over-year revenue growth

For earnings history and earnings-related data on Bruker (BRKR) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c